Bavarian Nordic may start producing covid-19 vaccines next year

If research results and financing pan out, vaccine company Bavarian Nordic reports that a Danish-developed covid-19 vaccine might be ready by next year.

Photo: Bavarian Nordic / PR

If everything comes together, Denmark may have production capacity for a coronavirus vaccine in place as soon as next year. Danish biotech company Bavarian Nordic announced this in relation to Danish Prime Minister Mette Frederiksen's plan that covid-19 vaccines will be produced on Danish soil in 2022.

Bavarian Nordic and scientists from Copenhagen University are currently devleoping a coronavirus vaccine and plan to initiate a phase II trial before the end of June. Bavarian still needs to raise capital for the final phase III trial, but if both the trials and financing efforts are successful, the vaccine might be ready as soon as next year, notes Bavarian Nordic Vice President Investor Relations & Communications Rolf Sass Sørensen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs